Dicot Pharma invites to a Q&A session on TO 6

Uppsala, March 17, 2025. Dicot Pharma invites to a Q&A session regarding the ongoing exercise of warrants in TO 6. The Q&A session will take place via Zoom on March 20 at 12.30. The session will be held in Swedish.

Dicot Pharma's warrants of series TO 6 have a redemption period and can be exercised March 17-31. To answer any questions, a Q&A session in Swedish will take place via Zoom on Thursday, March 20 at 12.30 and will also be available for viewing afterwards. Questions can be asked online at the session or before via [email protected].

CEO Elin Trampe comments: "We want to enable our existing but also potential new warrant holders to ask questions live directly to the company. We will start with a short status update and then open up for questions."

To register to attend the live Q&A session, please go to

https://us02web.zoom.us/webinar/register/WN_kZrwRSWgT5eQur7vueiMIQ

Information on how to subscribe, use of proceeds, etc. is sent to both warrant and share holders registered in Sweden and should reach the recipients around March 19. Information is also available on the website https://www.dicotpharma.com/en/investor-relations/reports-and-issues/to-6-warrants/